George D. Dangas, MD, PhD, FACC

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Janssen Pharmaceuticals, Inc(MODEST), Biosensors(MODEST) OWNERSHIP/PARTNERSHIP/PRINCIPAL: Applied Therapeutics(SIGNIFICANT), STEL(SIGNIFICANT), STEL(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Astra-Zeneca(NONE), Daiichi Sankyo(NONE), Abbott Laboratories(SIGNIFICANT) OTHER FINANCIAL BENEFIT: ControlRad(MODEST), WebMD(MODEST), Elixir(SIGNIFICANT)

View Full Disclosure